QTTB — Q32 Bio Cashflow Statement
0.000.00%
Last trade - 00:00
- $352.43m
- $229.61m
- $1.16m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -104 | -129 | -95.8 | -5 | -113 |
Depreciation | |||||
Non-Cash Items | 5.78 | 14.9 | 19.5 | -113 | 23.4 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.463 | 11.5 | -41.8 | 3.35 | -7.21 |
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -91.4 | -94.3 | -110 | -114 | -96.2 |
Capital Expenditures | -21.8 | -3.73 | -2.4 | -1.28 | -0.228 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -30 | 209 | -48.4 | 38 | 102 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -51.8 | 205 | -50.8 | 36.7 | 101 |
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 158 | 53.1 | 52.2 | 0.596 | 0.184 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 15.1 | 164 | -108 | -76.3 | 5.28 |